{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:34:00Z","timestamp":1790922840861,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3724-x","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T09:02:51Z","timestamp":1548061371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0969-0699","authenticated-orcid":false,"given":"Agnes N.","family":"Kiragga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mubiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Kambugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"issue":"9","key":"3724_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/0956462413515639","volume":"25","author":"E Larson","year":"2014","unstructured":"Larson E, et al. Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa. Int J STD AIDS. 2014;25(9):636\u201342.","journal-title":"Int J STD AIDS"},{"key":"3724_CR2","unstructured":"UNAIDS. Fact Sheet - Latest statistics on the status of the AIDS epidemic. 2017 [cited 2017 24th July ]."},{"key":"3724_CR3","unstructured":"UNAIDS, Global AIDS Update 2016, UNAIDS."},{"issue":"8","key":"3724_CR4","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","volume":"4","author":"Antiretroviral Therapy Cohort C","year":"2017","unstructured":"Antiretroviral Therapy Cohort C. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349\u201356.","journal-title":"Lancet HIV"},{"key":"3724_CR5","unstructured":"Commission, M.o.H.N.A. Treatment of AIDS Guidelines for the Ise of Antiretroviral Therapy in Malawi. Lilongwe; 2003."},{"issue":"9525","key":"3724_CR6","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/S0140-6736(06)68809-0","volume":"367","author":"AD Harries","year":"2006","unstructured":"Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet. 2006;367(9525):1870\u20132.","journal-title":"Lancet"},{"key":"3724_CR7","unstructured":"Ministry of Health Uganda. Uganda National Antiretroviral Treatment and Care Guidelines for Adults, Adolescents and Children. Released 2003."},{"issue":"9513","key":"3724_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","volume":"367","author":"P Braitstein","year":"2006","unstructured":"Braitstein P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817\u201324.","journal-title":"Lancet"},{"issue":"10100","key":"3724_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"Global","year":"2017","unstructured":"Global. Regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151\u2013210.","journal-title":"Lancet"},{"issue":"6","key":"3724_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1086\/605500","volume":"49","author":"B Castelnuovo","year":"2009","unstructured":"Castelnuovo B, et al. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort. Clin Infect Dis. 2009;49(6):965\u201372.","journal-title":"Clin Infect Dis"},{"key":"3724_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1472-698X-12-11","volume":"12","author":"S Nwaka","year":"2012","unstructured":"Nwaka S, et al. Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent. BMC Int Health Hum Rights. 2012;12:11.","journal-title":"BMC Int Health Hum Rights"},{"issue":"2","key":"3724_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","volume":"46","author":"MR Kamya","year":"2007","unstructured":"Kamya MR, et al. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46(2):187\u201393.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"3724_CR13","doi-asserted-by":"publisher","first-page":"e0142722","DOI":"10.1371\/journal.pone.0142722","volume":"10","author":"B Castelnuovo","year":"2015","unstructured":"Castelnuovo B, et al. Outcomes in a Cohort of patients started on Antiretroviral treatment and followed up for a decade in an Urban Clinic in Uganda. PLoS One. 2015;10(12):e0142722.","journal-title":"PLoS One"},{"key":"3724_CR14","volume-title":"Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach","author":"WHO","year":"2013","unstructured":"WHO, Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach. 2013."},{"issue":"6","key":"3724_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/cid\/cix915","volume":"66","author":"Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy","year":"2018","unstructured":"Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy. Collaborative study of treatment programs. Clin Infect Dis. 2018;66(6):893\u2013903.","journal-title":"Clin Infect Dis"},{"key":"3724_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.11604\/pamj.2017.27.48.8917","volume":"27","author":"A Saavedra","year":"2017","unstructured":"Saavedra A, et al. Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu teaching hospital. Pan Afr Med J. 2017;27:48.","journal-title":"Pan Afr Med J"},{"issue":"4","key":"3724_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/QAI.0b013e3181acb4e5","volume":"51","author":"AL French","year":"2009","unstructured":"French AL, et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr. 2009;51(4):399\u2013406.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"3724_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.7196\/SAMJ.2017.v107i12.12458","volume":"107","author":"P Groenewald","year":"2017","unstructured":"Groenewald P, et al. Mortality trends in the City of Cape Town between 2001 and 2013: reducing inequities in health. S Afr Med J. 2017;107(12):1091\u20138.","journal-title":"S Afr Med J"},{"issue":"1","key":"3724_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12963-017-0145-1","volume":"15","author":"A Misganaw","year":"2017","unstructured":"Misganaw A, et al. National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990-2015: findings from the global burden of disease study 2015. Popul Health Metrics. 2017;15(1):29.","journal-title":"Popul Health Metrics"},{"issue":"1","key":"3724_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4067\/s0716-10182018000100041","volume":"35","author":"B Gamboa-Acuna","year":"2018","unstructured":"Gamboa-Acuna B, et al. Factors associated to survival in patients with HIV-TB in the Department of Infectious Diseases of the Arzobispo Loayza National Hospital, Peru, since 2004 to 2012. Rev Chil Infectol. 2018;35(1):41\u20138.","journal-title":"Rev Chil Infectol"},{"key":"3724_CR21","doi-asserted-by":"publisher","first-page":"25382","DOI":"10.3402\/gha.v7.25382","volume":"7","author":"SD Hamusse","year":"2014","unstructured":"Hamusse SD, et al. Fifteen-year trend in treatment outcomes among patients with pulmonary smear-positive tuberculosis and its determinants in Arsi zone, Central Ethiopia. Glob Health Action. 2014;7:25382.","journal-title":"Glob Health Action"},{"key":"3724_CR22","doi-asserted-by":"crossref","unstructured":"Onyango DO, et al. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya, e0188235. PLoS One. 2017;12(11).","DOI":"10.1371\/journal.pone.0188235"},{"issue":"suppl_2","key":"3724_CR23","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1093\/cid\/cix1141","volume":"66","author":"FA Post","year":"2018","unstructured":"Post FA, et al. Causes and timing of mortality and morbidity among late presenters starting Antiretroviral Therapy in the REALITY trial. Clin Infect Dis. 2018;66(suppl_2):S132\u20139.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"3724_CR24","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897\u2013908.","journal-title":"AIDS"},{"key":"3724_CR25","doi-asserted-by":"publisher","first-page":"d6792","DOI":"10.1136\/bmj.d6792","volume":"343","author":"J Mermin","year":"2011","unstructured":"Mermin J, et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ. 2011;343:d6792.","journal-title":"BMJ"},{"issue":"2","key":"3724_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/cid\/ciu261","volume":"59","author":"SM Ingle","year":"2014","unstructured":"Ingle SM, et al. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients. Clin Infect Dis. 2014;59(2):287\u201397.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3724_CR27","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1086\/592115","volume":"47","author":"RD Moore","year":"2008","unstructured":"Moore RD, et al. Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. Clin Infect Dis. 2008;47(8):1102\u20134.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3724_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/605578","volume":"49","author":"AC Ross","year":"2009","unstructured":"Ross AC, et al. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis. 2009;49(7):1119\u201327.","journal-title":"Clin Infect Dis"},{"key":"3724_CR29","doi-asserted-by":"crossref","unstructured":"Karat, A.S., et al., Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: comparing verbal autopsy, minimally-invasive autopsy, and research data. PLoS One, 2017. 12(3): p. e0174097.","DOI":"10.1371\/journal.pone.0174097"},{"issue":"8","key":"3724_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1365-3156.2011.02798.x","volume":"16","author":"JA Cox","year":"2011","unstructured":"Cox JA, et al. Autopsy acceptance rate and reasons for decline in Mulago hospital, Kampala, Uganda. Tropical Med Int Health. 2011;16(8):1015\u20138.","journal-title":"Tropical Med Int Health"},{"key":"3724_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2018.00212","volume":"9","author":"A Song","year":"2018","unstructured":"Song A, et al. From CD4-based initiation to treating all HIV-infected adults immediately: an evidence-based meta-analysis. Front Immunol. 2018;9:212.","journal-title":"Front Immunol"},{"issue":"8","key":"3724_CR32","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1016\/S2352-3018(17)30086-3","volume":"4","author":"IT Katz","year":"2017","unstructured":"Katz IT, Maughan-Brown B. Improved life expectancy of people living with HIV: who is left behind? Lancet HIV. 2017;4(8):e324\u20136.","journal-title":"Lancet HIV"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3724-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T19:09:35Z","timestamp":1579547375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3724-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3724"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3724-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the Makerere University Faculty of Medicine Research and Ethics Committee (Approval number: 016\u20132004) and the Uganda National Council for Science and Technology (Approval number: MV 853). All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"77"}}